|

BCNU Clinical Trials

3 actively recruiting trials across 3 locations

Also known as: 1,3-bis [2-chloroethyl]-1-nitrosourea, BiCNU, Carmustine, Hepatic Chemoembolization, bis-chloroethylnitrosourea

Pipeline

Phase 1: 1Phase 2: 1Phase 1/2: 1

Top Sponsors

  • Thomas Jefferson University1
  • Masonic Cancer Center, University of Minnesota1
  • General Oncology, Inc.1

Indications

  • Cancer3
  • Liver Disease1
  • Stage 4 Pancreatic Cancer1
  • Adenocarcinoma of the Breast1
  • Pancreas Cancer, Recurrent1

Boston, Massachusetts1 trial

SHARON: A Clinical Trial for Metastatic Cancer Using Chemotherapy and Patients' Own Stem Cells

Massachusetts General Hospital

Phase 1

Minneapolis, Minnesota1 trial

Auto Stem Cell Transplant for Lymphoma Patients

Masonic Cancer Center, University of Minnesota

Phase 2

Philadelphia, Pennsylvania1 trial

Tebentafusp-tebn With LDT in Metastatic UM

Thomas Jefferson University

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.